Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
复制标题
眼睑淋巴瘤样丘疹病、皮肤间变性大细胞淋巴瘤和间变性大细胞淋巴瘤中 CD30 淋巴增殖的谱。
DOI:
10.1016/j.ophtha.2009.07.013
复制
发表时间:
2010
期刊:
影响因子:
13.7
通讯作者:
Grossniklaus,HansE
中科院分区:
文献类型:
--
作者:
Sanka,RKrishna;EagleJr,RalphC;Wojno,TedH;Neufeld,KennethR;Grossniklaus,HansE
PURPOSETo report the clinicopathologic features of 3 patients with CD30+lymphoid proliferations of the eyelid.DESIGNRetrospective case series.PARTICIPANTSPatients with cutaneous CD30+lymphoproliferative lesions of the eyelid.METHODSThree patients with CD30+non-mycosis fungoides T-cell lymphoid infiltrates of the eyelid were identified. The histories, clinical findings, pathologic features including immunohistochemical staining, treatments, and outcomes were reviewed and compared.MAIN OUTCOME MEASURESPathologic findings including immunohistochemical analysis.RESULTSThe patients included an 81-year-old man, an 18-year-old man, and a 42-year-old woman with CD30+lymphoid proliferations of the eyelid and adjacent soft tissue. The first patient had an isolated crateriform eyelid lesion that was classified as lymphomatoid papulosis (LyP). The second patient had an isolated multinodular lesion of the eyelid that was classified as cutaneous anaplastic large cell lymphoma (cALCL). The third patient presented with eyelid edema with an underlying mass and was found to have widely disseminated anaplastic large cell lymphoma (ALCL). Diagnoses were dependent on clinical findings.CONCLUSIONSThe CD30+lymphoid proliferations represent a spectrum of conditions ranging from indolent LyP, to moderately aggressive cALCL, to highly aggressive ALCL. Interpretation of the pathologic findings in CD30+lymphoid proliferations is based in part on clinical findings. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any material discussed in this article.
登录
查看更多内容
影响因子:
1.7
作者:
Kyoung‐Ae Jang;Jung‐Chul Choi;Jee
通讯作者:
Jee
DOI:
--
发表时间:
1998
期刊:
American journal of ophthalmology-glaucoma
影响因子:
--
作者:
F. Hu;J. C. Lin;I. Chiang;K. Yeh
通讯作者:
K. Yeh
DOI:
--
发表时间:
1999
期刊:
A M A Archives of Ophthalmology
影响因子:
--
作者:
Elizabeth Tanzi;M. Edelman;P. Rosenbaum
通讯作者:
P. Rosenbaum
影响因子:
20.3
作者:
Schiemann, WP;Pfeifer, WM;Lodish, HF
通讯作者:
Lodish, HF
影响因子:
7.3
作者:
Rassidakis, GZ;Jones, D;Medeiros, LJ
通讯作者:
Medeiros, LJ